Filter by
Filter by
Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma (EC).
19 patients with EC treated with IMPT concurrently with chemotherapy. Clinical complete response was achieved in 84%.
The most common grade 3 acute toxicities...
Long-term outcome of a prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.
This MD Anderson study published in the Green Journal reported proton therapy for early stage NSCLC patients who were not suitable for SBRT due to lesion size...
Joint Estimation of Cardiac Toxicity and Recurrence Risks after Comprehensive Nodal Photon vs. PT for Breast Cancer.
Published in the Red Journal, this study generated proton plans for 41 left-side breast cancer patients who underwent postlumpectomy comprehensive nodal photon...